Sex, Male, n (%) | 81 (81.0) |
---|---|
Age, years, median (range) | 71 (43–85) |
Histology, Squamous cell carcinoma, n (%) | 85 (85.0) |
Stage I / II / III / IV, n | 25 / 25 / 37 / 13 |
Neoadjuvant chemotherapy, n (%) | 74 (74.0) |
Preoperative body weight, median (range), (kg) | 56.1 (40.0–78.0) |
Preoperative body mass index, median (range), (kg / m2) | 21.2 (15.1–30.0) |
Laparoscopic procedure, n (%) | 87 (87.0) |
Anastomosis, circular stapler / hand sewn, n | 91 / 9 |
Operative time, median (range), (min) | 612 (456–859) |
Blood loss, median (range), (mL) | 170 (40–1600) |
Complications, n (%) | |
Pneumonia | 12 (12.0) |
Anastomotic leakage | 12 (12.0) |
Recurrent nerve palsy | 28 (28.0) |
Surgical site infection | 21 (21.0) |
Hospital stay, median (range), (days) | 17.5 (10–201) |
Residual cancer, n (%) | 11 (11.0) |
Adjuvant therapy, n (%) | |
Chemotherapy | 45 (45.0) |
Chemo-radiotherapy | 1 (1.0) |
Median postoperative body weight at 1 / 3 / 6 / 12 months after the surgery (kg) | 52.2 / 50.0 / 49.5 / 51.5 |
Median postoperative weight rate at 1 / 3 / 6 / 12 months after the surgery (%) | 92.9 / 88.0 / 85.2 / 87.4 |
Duration until feeding catheter removal, median (range), (days) | 62 (6–316) |
Surgery for BOFJ, n (%) | 17 (17.0) |
Duration from esophagectomy to surgery for BOFJ, median (range), (days) | 226 (6–1941) |
Patient’s stature | |
Length of the abdominal axis, median (range), (mm) | 330 (265–380) |
Distance between the site of jejunostomy and midline, median (range), (mm) | 40 (20–70) |
Distance between the site of jejunostomy and navel line, median (range), (mm) | 30 (0–150) |
Distance between the site of jejunostomy and xiphoid process line, median (range), (mm) | 110 (50–180) |